| Univariate analysis |
|
|
|
|
| Patients without LNM |
0.099 |
0.559 (0.280-1.115) |
0.090 |
0.534 (0.259-1.102) |
| Patients with LNM |
0.111 |
1.400 (0.925-2.118) |
0.144 |
1.370 (0.898-2.091) |
| Patients without LNM (<12 months) |
0.399 |
1.615 (0.531-4.915) |
0.250 |
2.049 (0.603-6.967) |
| Patients without LNM (≥12 months) |
0.016 |
0.279 (0.099-0.788) |
0.022 |
0.297 (0.105-0.842) |
| Patients with LNM (<12 months) |
0.656 |
1.184 (0.563-2.488) |
0.682 |
1.174 (0.545-2.532) |
| Patients with LNM (≥12 months) |
0.146 |
1.452 (0.878-2.400) |
0.173 |
1.426 (0.856-2.375) |
| Patients without LNM (<29 months) |
0.553 |
1.252 (0.596-2.629) |
0.552 |
1.272 (0.576-2.810) |
| Patients without LNM (≥29 months) |
0.199 |
0.258 (0.033-2.043) |
0.220 |
0.272 (0.034-2.181) |
| Patients with LNM (<29 months) |
0.515 |
1.163 (0.738-1.832) |
0.831 |
1.052 (0.662-1.672) |
| Patients with LNM (≥29 months) |
0.013 |
4.206 (1.362-12.987) |
0.041 |
3.288 (1.048-10.318) |
| I-II stage |
0.151 |
0.649 (0.360-1.170) |
0.143 |
0.634 (0.345-1.166) |
| III-IVa Stage |
0.218 |
1.323 (0.848-2.065) |
0.222 |
1.328 (0.842-2.096) |
| I-II stage (<12 months) |
0.276 |
2.003 (0.575-6.978) |
0.477 |
1.568 (0.453-5.421) |
| I-II Stage (≥12 months) |
0.054 |
0.494 (0.241-1.013) |
0.077 |
0.522 (0.254-1.073) |
| III-IVa stage (<12 months) |
0.625 |
1.197 (0.581-2.467) |
0.556 |
1.255 (0.589-2.672) |
| III-IVa Stage (≥12 months) |
0.315 |
1.341 (0.757-2.375) |
0.340 |
1.328 (0.742-2.378) |
| I-II stage (<29 months) |
0.987 |
0.994 (0.506-1.952) |
0.786 |
0.907 (0.451-1.827) |
| I-II Stage (≥29 months) |
0.470 |
0.627 (0.176-2.228) |
0.535 |
0.667 (0.185-2.398) |
| III-IVa stage (<29 months) |
0.430 |
1.211 (0.753-1.948) |
0.368 |
1.252 (0.767-2.044) |
| III-IVa Stage (≥29 months) |
0.037 |
5.234 (1.105-24.798) |
0.099 |
3.665 (0.785-17.115) |
